In contrast, Wang et al. reported that upregulation of METTL14 directly targets the downstream PERP mRNA (p53 effector related to PMP-22) in an m6A-dependent manner, promoting the growth and metastasis of pancreatic cancer. Here, METTL14 is linked to familial pancreatic carcinoma.